News
There are currently no news stories available for this symbol.
RELATED RESOURCES |
Snapshot: XDNAKELLY CRISPR & GENE EDITING TECHNOLOGY ETF11.6179 as of 4:15:00pm ET 02/06/2023
Quotes delayed at least 15 min.
Log in for real time quote.
|
ETP TypeETF Net Assets
|
30-day SEC Yield AS OF -- | -- |
---|---|
Distribution Yield (TTM) AS OF 01/31/2023 |
0.69% |
XDNA KELLY CRISPR & GENE EDITING TECHNOLOGY ETF |
Asset Class Median | |
---|---|---|
Volume (10-Day Avg) AS OF 02/03/2023 |
2.1K | 24.2M |
1 Month Market Total Return AS OF 02/04/2023 |
+18.42 | +10.77% |
1 Year Market Total Return AS OF 01/31/2023 |
-18.32 | -8.45% |
3 Year Annualized Market Total Return AS OF 01/31/2023 |
-- | +7.81% |
Beta (1 Year Month-End) AS OF 02/04/2023 |
0.93% | 1.09 |
Annual Turnover Ratio AS OF -- |
-- | 28.00% |
Net Expense Ratio AS OF 12/29/2022 |
0.78% | 0.53% |
NAV Return | Market Return | |
---|---|---|
1 Year | -- | -- |
3 Year | -- | -- |
5 Year | -- | -- |
10 Year | -- | -- |
Life | -31.92 | -31.90 |
The performance data featured represents past performance, which is no guarantee of future results. Investment return and principal value of an investment will fluctuate; therefore, you may have a gain or loss when you sell your shares. Current performance may be higher or lower than the performance data quoted.
More about Performance & RiskTMO | Thermo Fisher Scientific Inc | 10.71% |
---|---|---|
BEAM | Beam Therapeutics Inc | 9.84% |
CRISPR Therapeutics AG | 9.73% | |
NTLA | Intellia Therapeutics Inc | 8.62% |
PSTX | Poseida Therapeutics Inc Ordinary Shares | 7.19% |
PRME | Prime Medicine Inc | 4.81% |
VERV | Verve Therapeutics Inc | 4.61% |
SGMO | Sangamo Therapeutics Inc | 4.49% |
EDIT | Editas Medicine Inc | 4.39% |
ABBV | AbbVie Inc | 4.32% |
Commentary